Dyne Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.About DYN
Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy.
CEOJohn G. Cox
CEOJohn G. Cox
Employees258
Employees258
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2017
Founded2017
Employees258
Employees258
DYN Key Statistics
Market cap3.00B
Market cap3.00B
Price-Earnings ratio-5.12
Price-Earnings ratio-5.12
Dividend yield—
Dividend yield—
Average volume3.02M
Average volume3.02M
High today$18.88
High today$18.88
Low today$18.11
Low today$18.11
Open price$18.37
Open price$18.37
Volume3.06M
Volume3.06M
52 Week high$25.00
52 Week high$25.00
52 Week low$6.36
52 Week low$6.36
Stock Snapshot
As of today, Dyne Therapeutics(DYN) shares are valued at $17.86. The company's market cap stands at 3B, with a P/E ratio of -5.12.
During the trading session on 2026-03-17, Dyne Therapeutics(DYN) shares reached a daily high of $18.88 and a low of $18.11. At a current price of $17.86, the stock is -1.4% higher than the low and still -5.4% under the high.
Trading volume for Dyne Therapeutics(DYN) stock has reached 3.06M, versus its average volume of 3.02M.
The stock's 52-week range extends from a low of $6.36 to a high of $25.00.
The stock's 52-week range extends from a low of $6.36 to a high of $25.00.
Analyst ratings
88%
of 16 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own DYN. This list is generated using Robinhood data, and it’s not a recommendation.